Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
Showing 47,581 - 47,600 results of 226,405 for search '(( a ((((teer decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a largest decrease ))', query time: 1.46s Refine Results
  1. 47581
    Data_Sheet_1_Effects of a 12-week whole-grain or refined wheat intervention on plasma acylcarnitines, bile acids and signaling lipids, and association with liver fat: A post-hoc metabolomics study of an randomized controlled trial.pdf

    Data_Sheet_1_Effects of a 12-week whole-grain or refined wheat intervention on plasma acylcarnitines, bile acids and signaling lipids, and association with liver fat: A post-hoc me... by Anouk Gijbels (11050350)

    Published 2022
    “…</p>Methods<p>Targeted metabolomics of plasma obtained from a concluded 12-week double-blind, randomized controlled trial was performed. …”
    Save to List
    Saved in:
  2. 47582
    Image_4_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png

    Image_4_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

    Published 2021
    “…</p>Results<p>We discovered that the levels of circFAM114A2 were decreased in urothelial carcinoma cell lines and tissues. …”
    Save to List
    Saved in:
  3. 47583
    Image_6_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png

    Image_6_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

    Published 2021
    “…</p>Results<p>We discovered that the levels of circFAM114A2 were decreased in urothelial carcinoma cell lines and tissues. …”
    Save to List
    Saved in:
  4. 47584
    Image_5_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png

    Image_5_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

    Published 2021
    “…</p>Results<p>We discovered that the levels of circFAM114A2 were decreased in urothelial carcinoma cell lines and tissues. …”
    Save to List
    Saved in:
  5. 47585
    Image_7_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png

    Image_7_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

    Published 2021
    “…</p>Results<p>We discovered that the levels of circFAM114A2 were decreased in urothelial carcinoma cell lines and tissues. …”
    Save to List
    Saved in:
  6. 47586
    <b>In-hospital DIAbetes management by a diabetes TEam and insulin titration algorithms based on Continuous glucose monitoring or point-of-care glucose testing in patients with type 2 diabetes (DIATEC) </b>– <b>a randomised controlled trial</b>

    <b>In-hospital DIAbetes management by a diabetes TEam and insulin titration algorithms based on Continuous glucose monitoring or point-of-care glucose testing in patients with type... by Mikkel T. Olsen (20564694)

    Published 2025
    “…Results: The CGM-arm achieved a higher TIR (median, IQR) of 77.6% (24.4) vs 62.7% (31.5) in the POC-arm (p <.001). …”
    Save to List
    Saved in:
  7. 47587
    Image_3_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png

    Image_3_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

    Published 2021
    “…</p>Results<p>We discovered that the levels of circFAM114A2 were decreased in urothelial carcinoma cell lines and tissues. …”
    Save to List
    Saved in:
  8. 47588
    Image_1_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png

    Image_1_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

    Published 2021
    “…</p>Results<p>We discovered that the levels of circFAM114A2 were decreased in urothelial carcinoma cell lines and tissues. …”
    Save to List
    Saved in:
  9. 47589
    Image_2_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png

    Image_2_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

    Published 2021
    “…</p>Results<p>We discovered that the levels of circFAM114A2 were decreased in urothelial carcinoma cell lines and tissues. …”
    Save to List
    Saved in:
  10. 47590
    DataSheet1_A performance evaluation of random forest, artificial neural network, and support vector machine learning algorithms to predict spatio-temporal land use-land cover dynamics: a case from lusaka and colombo.docx

    DataSheet1_A performance evaluation of random forest, artificial neural network, and support vector machine learning algorithms to predict spatio-temporal land use-land cover dynam... by Bwalya Mutale (19650661)

    Published 2024
    “…<p>Reliable information plays a pivotal role in sustainable urban planning. With advancements in computer technology, geoinformatics tools enable accurate identification of land use and land cover (LULC) in both spatial and temporal dimensions. …”
    Save to List
    Saved in:
  11. 47591
    Table_1_Relationship between moderate-to-vigorous, light intensity physical activity and sedentary behavior in a prospective cohort of older French adults: a 18-year follow-up of mortality and cardiovascular events ─ the PROOF cohort study.DOCX

    Table_1_Relationship between moderate-to-vigorous, light intensity physical activity and sedentary behavior in a prospective cohort of older French adults: a 18-year follow-up of m... by Caroline Dupré (8699034)

    Published 2023
    “…For all-cause deaths, as well as CV deaths, the splines were significant for LPA (p = 0.04 and p = 0.01), and MVPA (p < 0.001 and p < 0.001), but not for SB (p = 0.24 and p = 0.90). There was a significant reduction in CV events when SB was decreasing from 10.9 to 3.3 h/d.…”
    Save to List
    Saved in:
  12. 47592
    Fig 5 -

    Fig 5 - by Henlay J. O. Magara (9972716)

    Published 2024
    “…The projections show a decrease in suitability around the equator and an increase in suitability in northern Europe and the Americas in 2050.…”
    Save to List
    Saved in:
  13. 47593
    Data_Sheet_2_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trial.PDF

    Data_Sheet_2_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomize... by Tanuja Nesari (12512864)

    Published 2022
    “…Among 47,827 participants, the trial group (n = 101) was evaluated with the positivity percentage of IgG COVID-19 and Immune Status Questionnaire (ISQ) scores as a primary outcome and the WHO Quality of Life Brief Version (QOL BREF) scores along with hematological parameters as a secondary outcome in comparison to the control group (n = 71).…”
    Save to List
    Saved in:
  14. 47594
    Data_Sheet_1_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trial.PDF

    Data_Sheet_1_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomize... by Tanuja Nesari (12512864)

    Published 2022
    “…Among 47,827 participants, the trial group (n = 101) was evaluated with the positivity percentage of IgG COVID-19 and Immune Status Questionnaire (ISQ) scores as a primary outcome and the WHO Quality of Life Brief Version (QOL BREF) scores along with hematological parameters as a secondary outcome in comparison to the control group (n = 71).…”
    Save to List
    Saved in:
  15. 47595
    Data_Sheet_3_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trial.PDF

    Data_Sheet_3_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomize... by Tanuja Nesari (12512864)

    Published 2022
    “…Among 47,827 participants, the trial group (n = 101) was evaluated with the positivity percentage of IgG COVID-19 and Immune Status Questionnaire (ISQ) scores as a primary outcome and the WHO Quality of Life Brief Version (QOL BREF) scores along with hematological parameters as a secondary outcome in comparison to the control group (n = 71).…”
    Save to List
    Saved in:
  16. 47596
    Data_Sheet_4_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trial.docx

    Data_Sheet_4_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomize... by Tanuja Nesari (12512864)

    Published 2022
    “…Among 47,827 participants, the trial group (n = 101) was evaluated with the positivity percentage of IgG COVID-19 and Immune Status Questionnaire (ISQ) scores as a primary outcome and the WHO Quality of Life Brief Version (QOL BREF) scores along with hematological parameters as a secondary outcome in comparison to the control group (n = 71).…”
    Save to List
    Saved in:
  17. 47597
    Toroidal metamaterials.

    Toroidal metamaterials. by Wen-Ying Zhou (10049543)

    Published 2025
    “…These findings suggest a significant decrease in the risk of electromagnetic exposure to human subjects by miniaturization. …”
    Save to List
    Saved in:
  18. 47598
    Human tissue dielectric parameters.

    Human tissue dielectric parameters. by Wen-Ying Zhou (10049543)

    Published 2025
    “…These findings suggest a significant decrease in the risk of electromagnetic exposure to human subjects by miniaturization. …”
    Save to List
    Saved in:
  19. 47599
    Human head modeling.

    Human head modeling. by Wen-Ying Zhou (10049543)

    Published 2025
    “…These findings suggest a significant decrease in the risk of electromagnetic exposure to human subjects by miniaturization. …”
    Save to List
    Saved in:
  20. 47600
    Variations in SAR for individual organizations.

    Variations in SAR for individual organizations. by Wen-Ying Zhou (10049543)

    Published 2025
    “…These findings suggest a significant decrease in the risk of electromagnetic exposure to human subjects by miniaturization. …”
    Save to List
    Saved in:

Search Tools: